Clinical Trial Update: Lebrikizumab in Moderate-to-severe Atopic Dermatitis [Phase 4]

View source ↗

Summary

A Phase 4 trial of Lebrikizumab for moderate-to-severe Atopic Dermatitis is currently recruiting. The study is sponsored by Johann E Gudjonsson and is in the re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Lebrikizumab (lebrikizumab)

Snippet

Sponsor: Johann E Gudjonsson MD PhD | Conditions: Atopic Dermatitis | Phase 4 | Status: RECRUITING